MktsMarkets

Precision BioSciences, Inc.
NASDAQ: DTILKey statistics
DTIL News
Stories mentioning DTIL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 10,838 | 34,204 | 13.00 | 18.00 | 29.00 | 638.00 | 576.00 | 49,898 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 13,110 | 14,464 | 13,352 | 12,768 | 13,588 | 15,907 | 13,084 | 17,225 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 19,913 | 21,696 | 20,680 | 21,895 | 22,141 | 25,484 | 21,851 | 25,752 |
| Operating Income (Loss) | (9,075) | 12,508 | (20,667) | (21,877) | (22,112) | (24,846) | (21,275) | 24,146 |
| Interest Income | ||||||||
| Interest Expense | 354.00 | 392.00 | 256.00 | 560.00 | ||||
| Other Expense | (9,366) | 6,740 | (1,105) | (1,643) | 1,547 | 7,101 | 4,850 | 8,603 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (18,441) | 20,133 | (21,772) | (23,520) | (20,565) | (17,745) | (16,425) | 32,749 |
| Earnings Per Share (Basic) | (0.75) | 1.57 | (1.84) | (2.13) | (2.21) | (2.60) | (2.25) | 4.70 |
| Earnings Per Share (Diluted) | (0.75) | 1.57 | (1.84) | (2.13) | (2.21) | (2.58) | (2.25) | 4.67 |
| Weighted Average Shares Outstanding (Basic) | 24,634 | 12,826 | 11,818 | 11,046 | 9,292 | 6,833 | 7,287 | 6,967 |
| Weighted Average Shares Outstanding (Diluted) | 24,634 | 12,826 | 11,818 | 11,046 | 9,292 | 6,884 | 7,287 | 7,012 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DTIL
Precision BioSciences, Inc. (NASDAQ: DTIL) is a stock listed on the Nasdaq Stock Market under the ticker symbol DTIL. It last traded at $8.32 (Nov 12, 2026, 2:20 PM ET), down 9.1% on the day. That gives Precision BioSciences a market capitalisation of $255.1M.
Over the past 52 weeks DTIL has traded between $3.53 and $11.29.
Revenue for the quarter ended Mar 31, 2026 was $10.8M; a net loss of $18.4M. Revenue was up 37272% from $29.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $10.8M | -$18.4M | -170.2% |
| Dec 31, 2025 | $34.2M | $20.1M | 58.9% |
| Sep 30, 2025 | $13.0K | -$21.8M | -167476.9% |
| Jun 30, 2025 | $18.0K | -$23.5M | -130666.7% |
From Precision BioSciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…